STOCK TITAN

Inotiv (NOTV) EVP receives 10,000 stock options at $0.5956 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Inotiv, Inc. reported that executive Andrea Castetter, EVP, General Counsel & Secretary, received a grant of 10,000 employee stock options. The options have an exercise price of $0.5956 per share and were awarded as a non-qualified stock option grant. According to the filing, the options vest over three years on a 40% / 30% / 30% schedule beginning on the first anniversary of the January 15, 2026 grant date, contingent on continued employment. After the grant, Castetter beneficially owns 10,000 stock options directly, and the options are scheduled to expire on January 15, 2036.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Castetter Andrea

(Last) (First) (Middle)
2701 KENT AVENUE

(Street)
WEST LAFAYETTE IN 47906

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Inotiv, Inc. [ NOTV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, General Counsel & Sec'y
3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $0.5956 01/15/2026 A 10,000 (1) 01/15/2036 Common Stock 10,000 $0 10,000 D
Explanation of Responses:
1. Represents a grant of non-qualified options, which have a three year vesting period of 40% / 30% / 30% beginning on the first anniversary of the grant date, subject to continued employment.
/s/ Andrea Castetter 01/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Inotiv (NOTV) report in this Form 4?

The Form 4 reports that executive Andrea Castetter received a grant of 10,000 non-qualified employee stock options for Inotiv common stock.

Who is the reporting person in this Inotiv (NOTV) Form 4 filing?

The reporting person is Andrea Castetter, who serves as Inotiv's EVP, General Counsel & Secretary.

What are the key terms of the 10,000 stock options granted at Inotiv (NOTV)?

The grant consists of 10,000 employee stock options with an exercise price of $0.5956 per share, expiring on January 15, 2036, and held directly by the executive.

How do the Inotiv (NOTV) options granted to Andrea Castetter vest?

The non-qualified options vest over three years on a 40% / 30% / 30% schedule, beginning on the first anniversary of the January 15, 2026 grant date, subject to continued employment.

How many Inotiv (NOTV) derivative securities does the executive hold after this transaction?

Following this grant, Andrea Castetter beneficially owns 10,000 employee stock options directly, as reported in the filing.

Is this Inotiv (NOTV) Form 4 transaction a purchase or a grant?

The transaction is reported with code "A" and represents a grant of non-qualified employee stock options to the executive, not an open-market purchase.

Inotiv Inc

NASDAQ:NOTV

NOTV Rankings

NOTV Latest News

NOTV Latest SEC Filings

NOTV Stock Data

19.50M
29.78M
11.3%
25.43%
6.11%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
WEST LAFAYETTE